ES8303412A1 - Procedimiento de obtencion de nuevas xantinas con actividad farmacologica - Google Patents

Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Info

Publication number
ES8303412A1
ES8303412A1 ES506046A ES506046A ES8303412A1 ES 8303412 A1 ES8303412 A1 ES 8303412A1 ES 506046 A ES506046 A ES 506046A ES 506046 A ES506046 A ES 506046A ES 8303412 A1 ES8303412 A1 ES 8303412A1
Authority
ES
Spain
Prior art keywords
xanthines
antiallergenic
antiasthmatic
halogen
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506046A
Other languages
English (en)
Other versions
ES506046A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigacion Tecnica y Aplicada SA
Original Assignee
Investigacion Tecnica y Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigacion Tecnica y Aplicada SA filed Critical Investigacion Tecnica y Aplicada SA
Priority to ES506046A priority Critical patent/ES8303412A1/es
Priority to FR8216580A priority patent/FR2514003A1/fr
Priority to IT68159/82A priority patent/IT1191214B/it
Priority to JP57173129A priority patent/JPS5872584A/ja
Priority to BE2/59858A priority patent/BE894597A/fr
Priority to GB08228432A priority patent/GB2107709A/en
Priority to DE19823237064 priority patent/DE3237064A1/de
Publication of ES506046A0 publication Critical patent/ES506046A0/es
Publication of ES8303412A1 publication Critical patent/ES8303412A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE XANTINAS Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES HIDROGENO O HALOGENO. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UNA PIPERAZINA DE FORMULA (III), EN LAS QUE X ES HALOGENO, Y R ES HIDROGENO O HALOGENO. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, EN PRESENCIA DE UN CATALIZADOR BASICO, A TEMPERATURAS COMPRENDIDAS ENTRE LA AMBIENTE Y LA DE EBULLICION DE LA MEZCLA. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIALERGICA, ANTIASMATICA Y ANTIHISTAMINICA.
ES506046A 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica Expired ES8303412A1 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES506046A ES8303412A1 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
FR8216580A FR2514003A1 (fr) 1981-10-06 1982-09-30 Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
IT68159/82A IT1191214B (it) 1981-10-06 1982-10-01 Xantine con attivita' farmacologica processo di ottenimento di esse e composizioni farmaceutiche che le contengono
JP57173129A JPS5872584A (ja) 1981-10-06 1982-10-01 新規キサンチン誘導体、その製法ならびに抗アレルギ−剤
BE2/59858A BE894597A (fr) 1981-10-06 1982-10-05 Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques les contenant et leur utilisation en medecine humaine
GB08228432A GB2107709A (en) 1981-10-06 1982-10-05 Xanthines
DE19823237064 DE3237064A1 (de) 1981-10-06 1982-10-06 Pharmakologisch aktive xanthine, verfahren zu ihrer gewinnung und pharmazeutische zubereitungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES506046A ES8303412A1 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Publications (2)

Publication Number Publication Date
ES506046A0 ES506046A0 (es) 1983-02-01
ES8303412A1 true ES8303412A1 (es) 1983-02-01

Family

ID=8483044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506046A Expired ES8303412A1 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Country Status (7)

Country Link
JP (1) JPS5872584A (es)
BE (1) BE894597A (es)
DE (1) DE3237064A1 (es)
ES (1) ES8303412A1 (es)
FR (1) FR2514003A1 (es)
GB (1) GB2107709A (es)
IT (1) IT1191214B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531085A1 (fr) * 1982-07-28 1984-02-03 Adir Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4710572A (en) * 1986-07-30 1987-12-01 American Home Products Corporation Histamine H1 antagonists
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB0009479D0 (en) * 2000-04-17 2000-06-07 Cipla Limited Antihistaminic compounds
TWI268930B (en) * 2000-07-28 2006-12-21 Ing-Jun Chen Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives and pharmaceutical composition thereof
EA017351B1 (ru) * 2007-03-29 2012-11-30 Общество С Ограниченной Ответственностью "Фармвинг" Средство противогистаминного антиаллергического действия и способ его получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133989A (en) * 1964-12-08 1968-11-20 Chugai Pharmaceutical Co Ltd Theophylline derivatives, their salts and process for preparing the same
US4426383A (en) * 1980-09-04 1984-01-17 Eisai Co., Ltd. Theophylline and theobromine derivatives
EP0087810B1 (en) * 1982-03-02 1986-06-25 Eisai Co., Ltd. Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient

Also Published As

Publication number Publication date
GB2107709A (en) 1983-05-05
JPS5872584A (ja) 1983-04-30
ES506046A0 (es) 1983-02-01
FR2514003A1 (fr) 1983-04-08
IT1191214B (it) 1988-02-24
DE3237064A1 (de) 1983-04-21
IT8268159A0 (it) 1982-10-01
BE894597A (fr) 1983-01-31

Similar Documents

Publication Publication Date Title
ES509449A0 (es) "un procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-3,4-c-piridina".
AU1699383A (en) 2-azabicyclo(2.2.2.)octane-3-carboxylic acid derivatives
GB2130580B (en) Derivatives of 4-oxo-1, 4-dihydronicotinic acid
EP0174464A3 (en) Substituted benzyl phthalazinone derivatives
ES8607271A1 (es) Amidinohidrazonas
ES514340A0 (es) "procedimiento de obtencion de nuevos derivados de piperazina".
EP0107735A4 (en) NEW PYRIDAZINONE DERIVATIVES.
ES8303412A1 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
RO83114A (ro) Procedeu pentru prepararea ditiazolil-(2,2')-disulfurilor
ES8304548A1 (es) "procedimiento de preparacion de derivados de fenetanolamina".
AU9141182A (en) 9-(3-(3,5-cis-dimethylpiperazino)propyl)carbazole for treatment of anxiety
ES462755A1 (es) Procedimiento para la preparacion de esteres bencilicos del acido 2-isopropil-4-fenil-3-butenico.
AU8036682A (en) Substituted aliphatic secondary amines
ES512230A0 (es) "procedimiento de preparacion de derivados (7e,9z)-alcadienoles".
EP0118564A4 (en) 4-AMINO-TETRAHYDRO-2-NAPHTOIC ACID DERIVATIVES.
NO872521L (no) Fremgangsmaate for overfoering av data.
ES511405A0 (es) "procedimiento de preparar compuestos 1(2h)-isoquinolonicos y similares".
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
DE3261303D1 (en) Process for the preparation of 4,4'-dibenzoylamino dianthrimide carbazole
AR227703A1 (es) Procedimiento para preparar 1-substituido-6-n-propil-8-metilimidazo(1,5-d)as-triazin-4(3h)-onas
JPS5293771A (en) Benzotriazoles
EP0162079A4 (en) USE OF ARG-PHE-AMIDE DERIVATIVES.
JPS5285178A (en) Di(tri-lower-alkylstannyl)pyrimidine derivatives
FI77023B (fi) Foerfarande foer framstaellning av 1-alkyl- eller 1,4-dialkyl-1h-pyrrol-2-aettiksyraestrar.
JPS5283520A (en) Novel 2-arylthio-cyclopentanones